|
| |
Dopamine Receptor, Dopamine Transporter & Dopamine Decarboxylase Antibodies
Dopamine is an endogenous catecholamine that influences many cellular
activities, including behavior, hormone synthesis and release, blood pressure
and intracellular ion transport. A family of at least 5 Dopamine Receptors (DR)
genes, D1-D5, have been identified based upon the amino acid identity,
pharmacological specificity and effector responses. DR have been classified into
either the D1-like (D1, D1B, and D5) or D2-like (D2, D3, and D4). The two
isoforms of D2R, D2 long (D2L) and short (D2S), are encoded by splice variants
of a single gene and differ only by the presence of an additional 29 AA in the
intracellular domain 3 of the D2 long form. It may play a role in the coupling
of the receptor to G-proteins. All members of this family have similar structure
and contain 7 putative transmembrane domains. A given cell or tissue may express
more than one DR. Specific radioligands do not exist that can differentiate
between these DR. Therefore, specific antibodies are needed to distinguish,
localize, and document changes in DR levels in cells and tissues under various
normal and pathological conditions.
ADI has made rabbit antibodies to specific to various DR using the DR-subtype
specific amino acid sequences. These antibodies should prove to be useful in
studying various DR using Western blotting and immunolocalization. Antibodies to
Dopamine, Dopamine Transporter (DAT) and Dopamine Decarboxylase (DDC) and
Dopamine Beta-hydroxylase (DBH) are also available.The control peptides, used
for immunization, are also available to determine specificity of antibodies.
|
Items |
Antigen
peptide location |
Ab
Host |
Expected
Ab Crossreactivity |
Neat
Antisera
Cat #
(100 ul) |
Aff.
Pure
Ab Cat #
(100 ug) |
* Control
Peptide Cat#
(100 ug) |
|
D1 (Ab#1) |
R, CP, 13aa |
Rb |
M,R, H, P |
D1R11-S |
D1R11-A |
D1R11-P |
|
D1 (Ab#2) |
R, 9 aa, EC4 |
Rb |
M, R, H |
D1R12-S |
D1R12-A |
D1R12-P |
|
D2 (L/S) (Ab#1) |
R, 11 aa, EC1 |
Rb |
M, R, H, B, C, S |
D2R11-S |
D2R11-A |
D2R11-P |
|
D2 (L) Ab # 2 |
R, 27 aa, CP3 |
Rb |
M, R, H, B |
D2R12-S |
D2R12-A |
D2R12-P |
|
D2 (L/S) (Ab# 3) |
H, 27 aa, CP3 |
Rb |
M, R, H, B |
D2R13-S |
D2R13-A |
D2R13-P |
|
D3 (Ab#1) |
H, 19 aa, EC3 |
Rb |
H |
D3R11-S |
D3R11-A |
D3R11-P |
|
D3 (Ab#2) |
R, 19 aa, EC3 |
Rb |
M, R |
D3R12-S |
D3R12-A |
D3R12-P |
|
D4 (Ab#1) |
M, 10 aa, EC3 |
Rb |
M, R, H |
D4R11-S |
D4R11-A |
D4R11-P |
|
D4
(Ab#2) |
H, 17 aa,
EC1 |
Rb |
H |
D4R12-S |
D4R12-A |
D4R12-P |
|
DAT
(Ab#1) |
R, 18 aa,
I |
Rb |
M, R, H,
D |
DAT11-S |
DAT11-A |
DAT11-P |
|
DAT
(Ab#2) |
H, 20
aa, CT |
G |
M, R, H |
- |
DAT12-A |
DAT12-P |
|
DAT (Ab#3)
|
H, 20 AA, ~CT
|
Rb
|
H, R, B
|
DAT13-S
|
DAT13-A
|
DAT13-P
|
|
DDC
(Ab # 1)
|
H,
17 aa, NT |
M,
Mono |
M,
R, H, B, D |
|
DDC11-M |
|
|
DDC (Ab # 2)
|
H, 16 aa, ~NT
|
Rb, poly
|
M, R, H, B, D
|
|
DDC12-A
|
DDC12-P
|
|
DBH (ab
# 1)
|
B
|
M, Mono |
M, R, H, B |
DBH11-S
|
DBH11-M
|
|
|
DBH
(ab # 2)
|
H, ~18 aa,
~NT
|
Rb
|
H, M, R
|
.
|
DBH12-A (50
ug)
|
DBPH12-P
|
|
Dopamine
(ab # 1)
|
Dopamine
|
Rb
|
All species |
DOP11-S
|
|
|
|
Dopamine (Ab #2)
|
Dopamine
|
m, mono
|
All Species
|
|
DOP12-M
|
|
|
Control
Rabbit IgG |
For use
in ELISA, Western, Immunohisto. |
20009-1 (1
mg) |
M= Mouse; R=Rat; H=Human; Ha=Hamster;
Rb=Rabbit; B=Bovine; C=Chicken; D=DOG;
CT= near C-terminus; NT=near
N-terminus; Internal=Middle of
protein; CL=Cytoplasmic loop; EC=Extracellular
domain; IC=Intracellular domain;
"Neat
Antisera" are the
unpurified antiserum and it is
suitable for ELISA and Western.
"Affinity pure"
antibodies have been over the
antigen-affinity column and
recommended for immunohistochemical
applications.
"Control peptides" can not
be used for Western as they are very
short peptides. They are intended for
ELISA or antibody competition studies.
All Products
are for in vitro research use only.
List of publications
using ADI's Antibodies to various
Dopamine Receptor and Related Products
DAT
Lotharius J
2002
Effect of Mutant -Synuclein on
Dopamine Homeostasis in a New Human
Mesencephalic Cell Line JBC 277,
38884-38894 WB IHC
human
Mesencephalic Cell Line.
D1R11
Banday AA/Hussain T
2003
Hypertension, Apr 2003; 10000069.
Dopamine-Mediated Inhibition of Renal
Na,K-ATPase Is Reduced by Insulin WB,
rat
kidney.
D1R11 Umrani DN/Hussain
T 2002
Hypertension 40: 880 - 885
Rosiglitazone Treatment Restores Renal
Dopamine Receptor Function in Obese
Zucker Rats WB,
rat.
D1R11 Beheray,
Sucheta
2000
Kidney Intl. 58, 712 Diminished
natriuretic response to dopamine in
old rats is due to an impaired D1-like
receptor-signaling pathway WB.
D2R
Kamiya T
2003
Oligomerization of adenosine A2A and
dopamine D2 receptors in living cells
Biophysical Research Communications,
Volume 306, Issue 2, 27 June 2003,
Pages 544-549. WB, IHCIF, IP
Human cells
cDNA.
D2R Farooqui SM
et al
1992
Biochem Biophys Res Commun. 1992 Apr
30;184(2):661-7. Production and
characterization of a monoclonal
antibody to dopamine D2 receptor:
comparison with a polyclonal antibody
to a different epitope WB, IHC.
D2R Sakata M
1992
Biochem
Biophys Res Commun. 575, 309-314 Post-transcriptional
regulation of loss of rat striatal D2
dopamine receptor during agina WB, 110
kda rat
brain.
D2R Farooqui SM
1991
J. Neurochem., 57, 1363-1369
Antibodies against synthetic peptide
predicted from the nucleotide sequence
of D2 R recognize native D2R protein
in rat striatum WB 120, 90, 85, 30 ka
rat brain.
D2R Brock JY
1992
Brain Res. 578, 244-250 Localization
of D2R in rat brain using polyclonal
antibody
IHC rat
brain 4%
PF.
D2R Farooqui SM
1992
Life Sci. 51, 1509-1516 An antibody to
D2R inhibits dopamine antagonist and
agonist binding to D2R cDNA
transfected mosue fibrobalst cells
ligand binding and flow cytometry.
D3R
Chu, Eugenia
2000
J. Pharmacol. Exp. Ther. 2000 293:
710-716 Mechanisms and Sites of Ocular
Action of
7-Hydroxy-2-dipropylaminotetralin: A
Dopamine3 Receptor Agonist IHC,
rabbit eyes.
D3R12
Zeng C
2002
Hypertension, 41, 724-729 Angiotensin
II Regulation of AT1 and D3 Dopamine
Receptors in Renal Proximal Tubule
Cells of SHR WB IP D3R from SC as well
rat RPY cells
D3R12 Ladines,
Cecilia A.
2001
Am J Physiol Regulatory Integrative
Comp Physiol 2001 281: R1071-R1078
Impaired renal D1-like and D2-like
dopamine receptor interaction in the
spontaneously hypertensive rat WB,
renal
cortical memb
45/90kda.
Notes:
Antibodies usage is indicated in the
following techniques:
WB=Western
Blot ;
IHC-Immunohistochmistry;
IP=Immunoprecipition;
Flow=Flow
cytometry;
|